Invea Therapeutics
Curated by SignalDeveloper of therapeutics for inflammatory gastrointestinal and hepatobiliary disorders
Overview
Developer of therapeutics for inflammatory gastrointestinal and hepatobiliary disorders. The company leverages artificial intelligence technology to accelerate and enhance drug discovery platforms for gastrointestinal disorders. The product pipeline includes INVA8001 for ulcerative colitis, and mastocytosis, and INVA8003 for inflammatory disorders.
Key facts
- Founded
- 2021
- Headquarters
- Guilford, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view